Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Checkin.com Group has signed an agreement with Creatio, a leading no-code platform for workflow automation and CRM

Checkin.com Group (STO:CHECK) has, building on its Technical Partnerships strategy, signed an agreement with Creatio, a global vendor of a no-code platform to automate workflows and CRM with a maximum degree of freedom. Checkin.com’s software for user identification and onboarding will be integrated into the CRM platform and made available to Creatio’s 6,500 customers globally. Creatio, the Salesforce challenger, which recently secured $200 million in a new funding round, employs 700 people and has partners in over 100 countries.Creatio’s no-code platform community targets most industries

Following the AI boom, drones are monitoring the building of new data centers across Northern Europe.

The world is witnessing an all time high of data center construction as a result of the growing digital transformation and computing-power demands for artificial intelligence. Drones are now being used to monitor data center developments in Northern Europe through a unique partnership by DroneDeploy and GlobheDroneDeploy, the leading aerial and ground reality capture platform, is working with Globhe, the largest drone data marketplace, to make drone pilots available on demand for their customers. Starting with data centers in Northern Europe, the two firms are beginning to work on a

STOREBRAND ASA: Reminder - Invitation to Result Presentation Q2 2024

In connection with the release of the results for Q2 2024, Storebrand invites to the following events:Friday 12 July 2024 07.30 CET Release of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.com/ir . 10.00 CET Live streamed investor and analyst conference in English. A webcast will be available for everyone to view on www.storebrand.com/ir, and will be available on demand afterwards. Analysts who would like to ask

Integrated Wärtsilä propulsion package supports decarbonisation and efficiency goals for James Fisher tankers

Wärtsilä Corporation, Press release, 11 July at 11 AM EESTTechnology group Wärtsilä will supply a fully integrated, mechanical drive, propulsion package for new 6000 dwt LNG-fuelled tankers being built for British fleet operator, James Fisher Everard Ltd., part of the James Fisher group of companies. The ships are under construction by China Merchants Jinling Shipyard (Yangzhou) Dingheng Co. in cooperation with design consultant FKAB Marine Design. The integrated package includes the high-performance Wärtsilä 25DF dual-fuel main engine.  The order was booked by

Invitation to Hoist Finance second quarter 2024 presentation

Hoist Finance will publish its Q2 2024 report on 26 July 2024, at approximately 07:30 AM (CEST). A combined presentation and teleconference will be held at 09:30 AM (CEST). Harry Vranjes, CEO, and Christian Wallentin, CFO and Deputy CEO, will present and comment on the report. If you wish to participate via webcast, please use the link below. You can ask written questions via the webcast. https://ir.financialhearings.com/hoist-finance-q2-report-2024 If you wish to participate via teleconference please register on the link below. After registration you will be provided with phone

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 156 – 11 JULY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to presentation of Prevas’ interim report January – June 2024

Prevas will publish the interim report for January-June 2024 on Friday, July 19, at 08:30. On the same day at 09.30 a.m. a press and analyst presentation will be held which can be followed via webcast with Finwire.[En bild som visar text, skärmbild, visitkort, Teckensnitt Automatiskt genererad beskrivning] The presentation is given in English by Magnus Welén (CEO) and Helena Burström (CFO) from Prevas AB. The presentation will be about Prevas’ development during the second quarter and first half of 2024. Follow the presentation here: https://www.finwire.tv/webcast/prevas/q2-2024/

Draft Determination

LEI 2138006E2VG89XLORJ06 Yorkshire Water receives PR24 draft determination from Ofwat   We submitted a substantial business plan to Ofwat outlining details of the investment we would like to make from 2025-2030.  Our plan ensures we can deliver on the things that our customers care about and for the environment. This morning, we have received Ofwat’s feedback on those plans and are pleased that they assessed our document as meeting their requirements.  We have yet to review the detail of what is proposed by Ofwat – and it would be premature to comment further at this time.  We

Olvi plc: Transfer of Treasury Shares Under Performance Share Plans

Olvi plc           Stock Exchange Release 11 July 2024 at 10.00 am Olvi plc: Transfer of Treasury Shares Under Performance Share Plans The Board of Directors of Olvi plc has resolved on directed issuance of shares without consideration to transfer a total of 528 Olvi plc Series A shares held as treasury shares to the company's key employee under Performance Share Plans 2022–2024 and 2023–2025 in accordance with the terms of the plans upon the retirement of a key person. Information on the Performance Share Plans was provided in stock exchange releases on 27 May 2022 and 2 March

Volvo Trucks at IAA 2024: New trucks and technologies supporting the journey towards zero emissions and zero accidents

Volvo Trucks’ line-up at the IAA 2024 exhibition will be packed with proof points of Volvo’s determination to decarbonize transport and prevent accidents. Volvo will show trucks with battery-electric powertrains, fuel cells and renewable fuels in combustion engines – a strategy that enables sustainable transport today and tomorrow.IAA 2024 will be a great opportunity to experience all of Volvo Trucks’ latest trucks and technologies – supporting our journey towards zero emissions and zero accidents Volvo Trucks at IAA 2024 will be a demonstration of a global product range that has never

Misen Energy AB (publ) will be delisted and last day of trading is 24 July 2024

Misen Energy AB (publ) ("Misen" or the "Company") announced on 10 July 2024 that the Company has applied for delisting of the Company's shares from Nasdaq First North Growth Market in Stockholm. Nasdaq Stockholm has approved the Company's application for delisting.The Board of Directors of Misen resolved on 10 July 2024 to apply for delisting of the Company's shares from Nasdaq First North Growth Market in Stockholm. According to the decision of Nasdaq Stockholm, Misen's shares will be delisted from Nasdaq First North Growth Market. The last day of trading in the Company's shares will be 24

Invitation for presentation of Pricer’s interim report for the second quarter 2024

Pricer AB will present its interim report for the second quarter 2024 in a webcast on July 18 at 13.00 CET.According to the financial calendar, Pricer will publish the report for the second quarter 2024 on Thursday, July 18 at approximately 7.30 am CET. Pricer hereby invites to a presentation of the report on the same day. Magnus Larsson, President and CEO, and Claes Wenthzel, acting CFO, will present the report and answer questions. Date: July 18, 2024 Time: 13.00 CET Link to the webcast: https://financialhearings.com/event/48514 

Cell Impact has been awarded silver medal by EcoVadis

EcoVadis is the world’s most trusted provider of business sustainability ratings and has recently awarded Cell Impact AB a silver medal.EcoVadis’ thorough evaluation of Cell Impact’s operational sustainability practices has resulted in a rating of 72/100 and thus placed Cell Impact in the top 94 percent among all companies rated in the past year – 46 percent above the industry average. “The EcoVadis rating validates and demonstrates our commitment to sustainability and supports our company mission to help transform the global energy system and reduce the world's dependency on fossil

Presentation of Probi’s Q2 Report 2024

Probi’s report for the second quarter 2024 will be published on Tuesday, 16 July at 8.00 a.m. CET. In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Anita Johansen and CFO Per Lindblad will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://ir.financialhearings.com/probi-q2-report-2024 

BioStock: PHI aims for US listing

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing regenerative medicine field. PHI is now taking an important step by applying for listing its shares in the US OTCQB market to enhance its presence and opportunities in the US. BioStock talked to CEO Patrik Eschricht to learn more about what this means for the company.Read the full article at biostock.se : https://www.biostock.se/2024/07/phi-aims-for-us-listing/ This is a press release from BioStock -

Distinct T-cell signatures observed at different stages of type 1 diabetes development

A study conducted at the University of Eastern Finland found distinct signatures in CD8-positive T cells in blood samples from children with newly diagnosed type 1 diabetes and in autoantibody-positive children who later developed type 1 diabetes. The study was published in the journal Diabetes. Type 1 diabetes is an autoimmune disease which usually develops in childhood. The symptomatic onset of type 1 diabetes results from a T-cell mediated destruction of insulin-producing beta cells in the pancreas. CD4-positive helper T cells orchestrate the autoimmune response, while CD8-positive

Aquaporin secures order with large EMEA water treatment company

Aquaporin is pleased to announce that it has secured an order valued at USD 300,000 from a large water treatment company in the EMEA region. This latest order comes from a recurring customer specializing in treating industrial wastewater, underscoring the strong, ongoing partnership between the two companies.The customer serves various market segments, including industries such as semiconductors, industrial plants, pharmaceuticals, and sewage treatment. The order consists of a variety of membrane modules from the CLEAR series, but predominantly CLEAR Classic 8040 and CLEAR Classic 4040. "

Re: Dividend Payment

For Immediate Release:       11 July 2024 ARK INVEST UCITS ICAV Re: Dividend Payment   The Directors of ARK INVEST UCITS ICAV (the “Fund”) wish to announce the following dividend paid by the Fund for the semi-annual dividend. Announcement Date: 11 July 2024 Ex-Date:  18 July 2024 Record Date:  19 July 2024 Payment Date:  30 July 2024   +------------------------+------------+--------+----------------+|Sub-Fund/Share Class |ISIN |Currency|Amount per Share|+------------------------+------------+--------+----------------+|RIZE GLOBAL SUSTAINABLE

Interim report January – June 2024: Continued strong profit and high rate of acquisitions

During the period, operational and financial progress remained strong due to rent increases, new development projects, new and extended rental contracts and positive acquisition effects.· Rental income increased by 19%, amounting to SEK 335 m (280). · Net operating income increased by 23%, amounting to SEK 286 m (232). · Profit from property management increased by 26% and amounted to SEK 182 m (145). · Earnings per share amounted to SEK 1.45 (0.65). · Net asset value (NAV) per share increased by 7% in the period and amounted to SEK 26.97. · Value changes in investment

John Mattson enters unique partnership with Stockholm Exergi to help with the transition of Stockholm’s energy system

Property company John Mattson and the energy company Stockholm Exergi have entered an agreement aimed at securing the long-term supply of district heating to John Mattson’s property portfolio and with the shared objective of reaching net zero for district heating production for the Stockholm region. The partnership entails investment by John Mattson in Stockholm Exergi’s transition of district heating over a longer period. At the same time, John Mattson is securing the supply of cost-effective and sustainable district heating for its properties.John Mattson’s investment will support

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 10 July 2024, has received a notification of major holding from JPMorgan Chase & Co, a company with its registered office in Wilmington, Delaware, USA. The notification refers to a decrease in the number of shares and voting rights in Kindred held by JPMorgan Chase & Co.According to the notification, JPMorgan Chase & Co held 4.89% of the shares and voting rights in Kindred as of 05 July 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website: https://

Faron Announces Positive FDA Feedback

Faron Pharmaceuticals Ltd.   (“Faron” or the “Company”)     Inside Information: Faron Announces Positive FDA Feedback   Company announcement, Inside Information, 11 July 2024 at 7:00 a.m. BST / 9:00 a.m. EEST   Key highlights -          Faron had a formal meeting with the FDA to discuss the registrational clinical development plan for bexmarilimab in the treatment myelodysplastic syndrome (MDS). -          The FDA acknowledged the difficulties of running a randomized study with a comparator in the relapsed / refractory setting (r/r) and instead proposed that

Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, “Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease,” was published recently by the Journal of Medical Economics %20is,MSA%5D)%20in%20selected%20cases)1.The comprehensive health economic analysis published in this study found that RefluxStop™ is highly likely to be a cost-effective treatment for GERD

There are no items matching the current filter
There are no more items matching the current filter
Back to top